专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US06716987B1 Derivatives of benzofuran or benzodioxazole compounds 失效
标题翻译：苯并呋喃或苯并恶唑化合物的衍生物
公开(公告)号：US06716987B1
公开(公告)日：2004-04-06
申请号：US10023091
申请日：2001-12-20
申请人： Etsuo Ohshima , Takashi Kawakita , Koji Yanagawa , Kyoichiro Iida , Rie Koike , Yoshisuke Nakasato , Tohru Matsuzaki , Kenji Ohmori , Soichiro Sato , Hidee Ishii , Haruhiko Manabe , Michio Ichimura , Fumio Suzuki
发明人： Etsuo Ohshima , Takashi Kawakita , Koji Yanagawa , Kyoichiro Iida , Rie Koike , Yoshisuke Nakasato , Tohru Matsuzaki , Kenji Ohmori , Soichiro Sato , Hidee Ishii , Haruhiko Manabe , Michio Ichimura , Fumio Suzuki
IPC分类号： C07D41300
CPC分类号： C07D307/79 , C07D307/94 , C07D405/06 , C07D405/12 , C07D405/14
摘要： An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R1 and R2 independently represent hydrogen, lower alkyl, cyano, —(CH2)n—E1—CO—G1 (wherein E1 represents a bond, O, or NH; and G1 represents hydrogen, substituted or unsubstituted lower alkyl, OR6, or NR7R8; and n represents an integer of 0 to 4), or the like; R1 and R2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R2, and R11 or R13 described below are combined to form a single bond; R3 represents hydrogen, phenyl, or halogen; R4 represents hydroxy, lower alkoxy, or the like; A represents —C(R9)(R10)— or O; B represents O, NR11, —C(R12)(R13)—, or —C(R14)(R15)— C(R16)(R17)—; D represents (i) —C(R18)(R19)—X— (wherein X represents —C(R21)(R22)—, S, or NR23), (ii) —C(R19a)═Y— [Y represents —C(R24)—Z— (wherein Z represents CONH, CONHCH2, or a bond), or N], or (iii) a bond; and R5 represents aryl, an aromatic heterocyclic group, cycloalkyl, pyridine-N-oxide, cyano, or lower alkoxycarbonyl; or pharmaceutically acceptable salts thereof.
摘要翻译：由下式（I）表示的含氧杂环化合物：其中R 1和R 2独立地表示氢，低级烷基，氰基， - （CH 2）nE 1 -CO-G 1（其中 E 1表示键，O或NH;且G 1表示氢，取代或未取代的低级烷基，OR 6或NR 7 R 8; n表示0〜 4）等; R 1和R 2相互结合形成饱和碳环和与其相邻的碳原子。或R 2，以及下述R 11或R 13组合形成单键; R 3表示氢，苯基或卤素; R 4表示羟基，低级烷氧基等; A表示-C（R 9）（R 10） - 或O; B表示O，NR 11，-C（R 12）（R 13） - 或-C（R 14）（R 15）-C（R 16）（R 16） <17>） - ; D表示（i）-C（R 18）（R 19）-X-（其中X表示-C（R 21）（R 22） - ，S或NR 23），（ii）-C（R 19）= Y- [Y表示-C（R 24） - Z-（其中Z表示CONH，CONHCH 2或键）或N]或（iii）一个债券 R 5表示芳基，芳香族杂环基，环烷基，吡啶-N-氧化物，氰基或低级烷氧基羰基; 或其药学上可接受的盐。

12. 发明授权

US06337724B1 Image display system 失效
标题翻译：图像显示系统
公开(公告)号：US06337724B1
公开(公告)日：2002-01-08
申请号：US08759626
申请日：1996-12-05
申请人： Toshio Itoh , Haruhiko Nagai , Tsunehiro Imamura , Takayoshi Semasa , Kenji Tatsumi , Shuji Iwata , Hiroshi Mitsuda , Yasuhito Myoi , Toshimasa Tomoda , Fumio Suzuki , Yoshisuke Ohtsuru
发明人： Toshio Itoh , Haruhiko Nagai , Tsunehiro Imamura , Takayoshi Semasa , Kenji Tatsumi , Shuji Iwata , Hiroshi Mitsuda , Yasuhito Myoi , Toshimasa Tomoda , Fumio Suzuki , Yoshisuke Ohtsuru
IPC分类号： G02F11335
CPC分类号： H04N9/12 , G09G2300/026
摘要： A plurality of liquid crystal modules is vertically and horizontally arranged, each of which is supplied light by a light source via optical fibers. A screen can be wound up at a cabinet. An image from each of the plurality of liquid crystal modules does not interfere one another because a light shielding board is installed.
摘要翻译：垂直和水平布置多个液晶模块，每个液晶模块通过光纤由光源供给光。屏幕可以在柜子上卷起。由于安装了遮光板，来自多个液晶模块中的每一个的图像不会彼此干涉。

13. 发明授权

US06306847B1 Condensed purine derivatives 失效
标题翻译：凝血嘌呤衍生物
公开(公告)号：US06306847B1
公开(公告)日：2001-10-23
申请号：US09090936
申请日：1998-06-05
申请人： Hiroshi Tsumuki , Mayumi Saki , Hiromi Nonaka , Michio Ichimura , Junichi Shimada , Fumio Suzuki , Shunji Ichikawa , Nobuo Kosaka
发明人： Hiroshi Tsumuki , Mayumi Saki , Hiromi Nonaka , Michio Ichimura , Junichi Shimada , Fumio Suzuki , Shunji Ichikawa , Nobuo Kosaka
IPC分类号： C07D48714
CPC分类号： C07D487/14
摘要： The present invention provides condensed purine derivatives or pharmacologically acceptable salts thereof exhibiting adenosine A3 acceptor antagonising activity, and having an antiasthmatic action, a bronchodilator action, an antiantiitching action, etc., and represented by the following formula (I): (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted aromatic heterocyclic group; R2 represents hydrogen, lower alkyl, alicyclic alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, or a substituted or unsubstituted aromatic heterocyclic group; R3 represents hydrogen, lower alkyl, or substituted or unsubstituted aralkyl; X1 and X2 are the same or different and each represents hydrogen, lower alkyl, substituted or unsubstituted aralkyl, or substituted or unsubstituted aryl; and n represents an integer of 0 to 3).
摘要翻译：本发明提供具有腺苷A3受体拮抗活性的缩合嘌呤衍生物或其药理学上可接受的盐，并具有抗哮喘作用，支气管扩张剂作用，抗脱除作用等，并由下式（I）表示:(其中R1表示取代或未取代的芳基或取代或未取代的芳族杂环基; R 2表示氢，低级烷基，脂环族烷基，取代或未取代的芳烷基，取代或未取代的芳基或取代或未取代的芳族杂环基; R 3表示氢，低级烷基或取代或未取代的芳烷基; X 1和X 2相同或不同，各自表示氢，低级烷基，取代或未取代的芳烷基或取代或未取代的芳基; n表示0〜3的整数。

14. 发明授权

US5815221A Projector apparatus 失效
标题翻译：投影仪
公开(公告)号：US5815221A
公开(公告)日：1998-09-29
申请号：US565249
申请日：1995-11-30
申请人： Masanori Kojima , Ko Nishino , Yasuhito Myoi , Masaaki Tanaka , Teruo Miyamoto , Fumio Suzuki , Fumio Itoh , Yoshisuke Otsuru
发明人： Masanori Kojima , Ko Nishino , Yasuhito Myoi , Masaaki Tanaka , Teruo Miyamoto , Fumio Suzuki , Fumio Itoh , Yoshisuke Otsuru
IPC分类号： G02F1/13 , G02B27/28 , G02F1/1335 , G02F1/13357 , G02F1/1347 , H04N9/31
CPC分类号： H04N9/3188 , H04N9/3105 , G02F1/133536 , G02F1/13362 , G02F2001/13355
摘要： A polarizing beam splitter extracts orthogonally polarized light beams from natural light and distributes those to liquid crystal panels, which modulate polarization states of those polarized light beams in accordance with a luminance signal and chrominance signals of video signals, respectively. The modulated light beams are combined by the same polarizing beam splitter, and the combined light is enlarged and projected onto a screen by a projection lens, to reproduce a projected image.
摘要翻译：偏振光束分离器从自然光中提取正交偏振光束，并将其分配到液晶面板，液晶面板分别根据视频信号的亮度信号和色度信号调制偏振光束的偏振状态。调制光束由相同的偏振分束器组合，并且组合的光被投影透镜放大并投影到屏幕上，以再现投影图像。

15. 发明授权

US5756735A Xanthine derivatives 失效
标题翻译：黄嘌呤衍生物
公开(公告)号：US5756735A
公开(公告)日：1998-05-26
申请号：US483159
申请日：1995-06-07
申请人： Fumio Suzuki , Akio Ishii , Hiromi Nonaka , Nobuo Kosaka , Shunji Ichikawa , Junichi Shimada
发明人： Fumio Suzuki , Akio Ishii , Hiromi Nonaka , Nobuo Kosaka , Shunji Ichikawa , Junichi Shimada
IPC分类号： C07D473/06
CPC分类号： C07D473/06
摘要： The present invention relates to novel xanthine derivatives of the formula (I) which are selectively antagonistic to an adenosine A.sub.2 receptor, and pharmaceutically acceptable salts thereof. Formula (I): ##STR1## In the formula, R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a propyl group, a butyl group or an allyl group; R.sup.3 represents a hydrogen atom or a lower alkyl group; Y.sup.1 and Y.sup.2 are the same or different and each represents a hydrogen atom or a methyl group; and Z represents a substituted or unsubstituted phenyl group, a pyridyl group, an imidazolyl group, a furyl group or a thienyl group.
摘要翻译：本发明涉及对腺苷A2受体选择性拮抗的式（I）的新颖黄嘌呤衍生物及其药学上可接受的盐。式（I）：（I）式中，R 1和R 2相同或不同，表示氢原子，丙基，丁基或烯丙基; R3表示氢原子或低级烷基; Y1和Y2相同或不同，各自表示氢原子或甲基; Z表示取代或未取代的苯基，吡啶基，咪唑基，呋喃基或噻吩基。

16. 发明授权

US5527908A Pyrazolothiazolopyrimidine derivatives 失效
标题翻译：吡唑并噻唑并嘧啶衍生物
公开(公告)号：US5527908A
公开(公告)日：1996-06-18
申请号：US94106
申请日：1993-08-05
申请人： Fumio Suzuki , Yoshisuke Nakasato , Kenji Ohmori , Tadafumi Tamura , Soichiro Sato , Hiroshi Tanaka
发明人： Fumio Suzuki , Yoshisuke Nakasato , Kenji Ohmori , Tadafumi Tamura , Soichiro Sato , Hiroshi Tanaka
IPC分类号： C07D513/14 , A61K31/505
CPC分类号： C07D513/14
摘要： Pyrazolothiazolopyrimidine derivatives represented by the Formula ##STR1## and pharmaceutically acceptable salts thereof are useful as anti-inflammatory, analgesic, immunomodulatory and anti-ulcer agents.
摘要翻译： PCT No.PCT / JP92 / 01595 Sec。 371日期：1993年8月5日 102（e）日期1993年8月5日PCT提交1992年12月7日PCT公布。公开号WO93 / 12120 PCT 日期：1992年6月24日。由式＆lt; IMAGE＆gt;表示的吡唑并噻唑并嘧啶衍生物及其药学上可接受的盐可用作抗炎，镇痛，免疫调节和抗溃疡剂。

17. 发明授权

US5521231A Process for producing thermoplastic copolymer powder 失效
标题翻译：生产热塑性共聚物粉末的方法
公开(公告)号：US5521231A
公开(公告)日：1996-05-28
申请号：US381888
申请日：1995-02-24
申请人： Fumio Suzuki , Haruki Sato , Masaki Sugihara , Wataru Hadano
发明人： Fumio Suzuki , Haruki Sato , Masaki Sugihara , Wataru Hadano
IPC分类号： C08F291/00 , C08J3/12 , C08J3/16 , C08F6/22
CPC分类号： C08F291/00 , C08J3/12 , C08J3/16 , C08J2321/02
摘要： A process for producing a thermoplastic polymer powder which comprises adding a polymer (B) and/or an inorganic compound (C) to a coagulation slurry or a powder of a thermoplastic polymer (A) obtained from emulsion polymerization and having a glass transition temperature Tg defined by the following equation (1), in an amount of 0.1-10 parts by weight to 100 parts by weight of the thermoplastic polymer (A), compacting the thermoplastic polymer (A) at a temperature in a range of (Tg-30) to (Tg+50).degree. C., and comminuting it:Tg=W.sub.1 .times.Tg.sub.1 +W.sub.2 .times.Tg.sub.2 + . . . +W.sub.n .times.Tg.sub.n ( 1)wherein n is the number of the monomers forming the thermoplastic polymer (A); W.sub.1, W.sub.2, . . . W.sub.n each represents weight fraction of each monomer i (i=1, 2, . . . n) in the polymer (A); and Tg.sub.1, Tg.sub.2, . . . Tg.sub.n each represents the glass transition temperature of the polymer composed of each monomer i. According to the present invention, it is possible to remarkably enhance bulk specific gravity of thermoplastic polymers as compared with the case using the methods known in the art.
摘要翻译： PCT No.PCT / JP93 / 01221 Sec。 371日期：1995年2月24日 102（e）1995年2月24日PCT PCT 1993年8月31日PCT公布。出版物WO94 / 05722 日本特开2002-1933年所述的热塑性聚合物粉末的制造方法，其特征在于，将聚合物（B）和/或无机化合物（C）添加到由乳液聚合得到的凝固浆料或热塑性聚合物（A）的粉末中并且具有由下式（1）定义的玻璃化转变温度Tg，相对于100重量份热塑性聚合物（A）为0.1-10重量份，在热塑性聚合物（A）的温度下压制热塑性聚合物（Tg-30）至（Tg + 50）℃的范围，并粉碎：Tg = W1xTg1 + W2xTg2 +。。。 + WnxTgn（1）其中n是形成热塑性聚合物（A）的单体数目; W1，W2，。。。 Wn分别表示聚合物（A）中各单体i（i = 1,2，...）的重量分数。和Tg1，Tg2。。。 Tgn各自表示由各单体i构成的聚合物的玻璃化转变温度。根据本发明，与使用本领域已知方法的情况相比，可以显着提高热塑性聚合物的体积比重。

18. 发明授权

US5400668A Superconducting magnet magnetically levitated transportation apparatus 失效
标题翻译：超导磁体磁悬浮运输装置
公开(公告)号：US5400668A
公开(公告)日：1995-03-28
申请号：US996138
申请日：1992-12-23
申请人： Toshio Hattori , Hiroshi Aoyama , Saburo Usami , Toshio Ishizuki , Tosuke Hirata , Shigeru Sakamoto , Yumiko Seki , Tadasi Sonobe , Fumio Suzuki , Sueo Kawai
发明人： Toshio Hattori , Hiroshi Aoyama , Saburo Usami , Toshio Ishizuki , Tosuke Hirata , Shigeru Sakamoto , Yumiko Seki , Tadasi Sonobe , Fumio Suzuki , Sueo Kawai
IPC分类号： B60L13/06 , H01F6/00 , H01F6/04 , H01L39/04 , G01M19/00 , B60L13/04 , H01F7/02
CPC分类号： B60L13/06 , H01F6/00 , B60L2200/26
摘要： A superconducting magnet includes a superconducting coil, an inner tank for containing the coil, a shield plate for covering the inner tank, and an outer tank for accommodating the superconducting coil, the inner tank and the shield plate. The inner tank is supported on the outer tank by a load support member and the outer tank forms a vacuum vessel. At least one of the inner tank, the load support member, the shield plate and the outer tank includes a detection arrangement for detecting abnormality and/or deterioration of the inner tank, load support member, shield plate and outer tank associated with the respective detection arrangement.
摘要翻译：超导磁体包括超导线圈，用于容纳线圈的内部容器，用于覆盖内部容器的屏蔽板以及用于容纳超导线圈，内部容器和屏蔽板的外部容器。内罐通过负载支撑构件支撑在外箱上，外罐形成真空容器。内箱，负载支承构件，屏蔽板和外箱中的至少一个包括用于检测与相应检测相关联的内箱，负载支承构件，屏蔽板和外箱的异常和/或劣化的检测装置安排。

19. 发明授权

US5192768A Pyrazoloquinoline derivatives 失效
标题翻译：吡唑啉醇衍生物
公开(公告)号：US5192768A
公开(公告)日：1993-03-09
申请号：US757988
申请日：1991-09-12
申请人： Fumio Suzuki , Yoshisuke Nakasato , Kenji Ohmori , Tadafumi Tamura , Hisashi Hosoe , Kazuhiro Kubo , Ikufumi Yoshitake
发明人： Fumio Suzuki , Yoshisuke Nakasato , Kenji Ohmori , Tadafumi Tamura , Hisashi Hosoe , Kazuhiro Kubo , Ikufumi Yoshitake
IPC分类号： C07D471/04
CPC分类号： C07D471/04
摘要： A pyrazoloquinoline derivative having the formula (I): ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 independently represent a hydrogen atom or a lower alkyl group; R.sup.4 represents a hydrogen atom, a lower alkyl group, a halogen-substituted lower alkyl group, or a lower alkoxycarbonyl group; the dotted line means that the pyrazole ring has two conjugated double bonds; and R.sup.4 is bonded to the nitrogen atom at the 1-position or 2-position, or pharmacologically acceptable salts thereof. These compounds exhibit excellent anti-inflammatory activity and hepatic insufficiency treating activity.

20. 发明授权

US5030265A Optical fiber coupler manufacturing device 失效
标题翻译：光纤耦合器制造装置
公开(公告)号：US5030265A
公开(公告)日：1991-07-09
申请号：US516500
申请日：1990-05-01
申请人： Fumio Suzuki , Noboru Kawakami , Yoshio Kikuchi , Ryozo Yamauchi
发明人： Fumio Suzuki , Noboru Kawakami , Yoshio Kikuchi , Ryozo Yamauchi
IPC分类号： G02B6/28
CPC分类号： G02B6/2835
摘要： A optical fiber coupler manufacturing device is disclosed for the manufacture of fused-elongated type optical fiber couplers. The disclosed invention provides an optical fiber coupler manufacturing device having a chassis, a pair of movable stands provided within the chassis forming a space therebetween, optical fiber mounting units for mounting and fixing two or more component optical fibers on the above mentioned pair of movable stands, and a drive mechanism whereby the pair of movable stands can be driven back and forth in a direction parallel to the longitudinal axes of the component optical fibers. By virtue of the space formed between the two movable stands, a heat source can be applied to the aligned portions of the component optical fibers, thereby effecting thermal fusing of the aligned portions, after which drawing out of the thus fused section can be effected using the above mentioned drive mechanism for the movable stands, and additionally, a protective case for surrounding and reinforcing the manufactured optical fiber coupler can easily be applied without removing the optical fiber coupler from the apparatus through the above described space.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式